Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort
Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort is a paper indexed in PICO Portal from OpenAlex.
How many citations does Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort have?
Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort has 0 citations in the OpenAlex counts PICO Portal stores.
When was Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort published?
Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort has 2025 year in the PICO Portal index.
What is the open-access status of Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort?
Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort has hybrid oa status in the PICO Portal index.
What is the DOI of Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort?
The DOI for Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort is on the source record.
What is the PMID of Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort?
The PMID for Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort is on the source record.
What is the OpenAlex record for Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort?
The OpenAlex for Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort is on the source record.